Delcaths, Praxis Hit 52-Week Highs on Strong Q2 Results
DCTH Delcath Systems Inc
$15.36 +2.13%
View chart & analysis → - 1Delcath Systems (DCTH) and Praxis Precision Medicines (PRAX) reached 52-week highs on Thursday after second-quarter results that beat expectations.
- 2DCTH posted revenue of $29.1 million and swung to a profit of $0.07 per share, then raised its 2026 revenue guidance to $104–108 million.
- 3PRAX reported a loss of $2.87 per share, beating the expected loss of $3.66, and holds $1.4 billion in cash to support its pipeline through 2028.
Source Stocktwits +1 · View original ↗
Nothing hidden: past picks and how they did against the S&P 500.